104 related articles for article (PubMed ID: 12225893)
1. Nitric oxide synthase I and VIP-activated signaling are affected in salivary glands of NOD mice.
Rosignoli F; Pérez Leirós C
J Neuroimmunol; 2002 Sep; 130(1-2):109-16. PubMed ID: 12225893
[TBL] [Abstract][Full Text] [Related]
2. Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice.
Rosignoli F; Goren NB; Pérez Leirós C
Clin Immunol; 2001 Oct; 101(1):86-93. PubMed ID: 11580230
[TBL] [Abstract][Full Text] [Related]
3. NOD mice exocrinopathy: towards a neuroimmune link.
Calafat M; Larocca L; Roca V; Pérez Leirós C
Neuroimmunomodulation; 2007; 14(3-4):175-81. PubMed ID: 18073511
[TBL] [Abstract][Full Text] [Related]
4. Lack of nitric oxide-mediated regulation of amylase secretion stimulated by VIP in parotid glands of NOD mice.
Roca V; Rosignoli F; Calafat M; Leirós CP
Int Immunopharmacol; 2004 Dec; 4(14):1837-44. PubMed ID: 15531299
[TBL] [Abstract][Full Text] [Related]
5. Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice.
Roca V; Larocca L; Calafat M; Aisemberg J; Meiss R; Franchi AM; Leirós CP
Reproduction; 2006 Dec; 132(6):931-8. PubMed ID: 17127753
[TBL] [Abstract][Full Text] [Related]
6. Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis.
Rosignoli F; Roca V; Meiss R; Leceta J; Gomariz RP; Pérez Leirós C
Clin Exp Immunol; 2005 Dec; 142(3):411-8. PubMed ID: 16297151
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
[TBL] [Abstract][Full Text] [Related]
8. VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages.
Larocca L; Calafat M; Roca V; Franchi AM; Leirós CP
Int Immunopharmacol; 2007 Oct; 7(10):1343-9. PubMed ID: 17673149
[TBL] [Abstract][Full Text] [Related]
9. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C expression in salivary gland acinar epithelial cells in non-obese diabetic mice, an experimental model for Sjögren's syndrome.
Tensing EK; Ma J; Hukkanen M; Fox HS; Li TF; Törnwall J; Konttinen YT
Rheumatol Int; 2005 Jan; 25(1):28-32. PubMed ID: 13680143
[TBL] [Abstract][Full Text] [Related]
11. Neuroimmune aspects of Sjogren's syndrome: role of VIP/VPAC system in immune and salivary gland epithelial cell function.
Vanesa H; Mario C; Esteban G; Laura F; Daniel P; Rosanna R; Claudia PL
Curr Pharm Des; 2014; 20(29):4760-5. PubMed ID: 24588828
[TBL] [Abstract][Full Text] [Related]
12. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.
Lodde BM; Mineshiba F; Wang J; Cotrim AP; Afione S; Tak PP; Baum BJ
Ann Rheum Dis; 2006 Feb; 65(2):195-200. PubMed ID: 15975969
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive Intestinal Peptide Protects Salivary Glands against Structural Injury and Secretory Dysfunction via IL-17A and AQP5 Regulation in a Model of Sjögren Syndrome.
Li C; Zhu F; Wu B; Wang Y
Neuroimmunomodulation; 2017; 24(6):300-309. PubMed ID: 29617700
[TBL] [Abstract][Full Text] [Related]
14. Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis.
Hauk V; Fraccaroli L; Grasso E; Eimon A; Ramhorst R; Hubscher O; Pérez Leirós C
Clin Exp Immunol; 2014 Sep; 177(3):662-70. PubMed ID: 24827637
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands.
Calafat M; Larocca L; Roca V; Hauk V; Pregi N; Nesse A; Pérez Leirós C
Arthritis Res Ther; 2009; 11(2):R53. PubMed ID: 19356238
[TBL] [Abstract][Full Text] [Related]
16. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
17. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
18. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy.
Yamachika S; Brayer J; Oxford GE; Peck AB; Humphreys-Beher MG
Clin Exp Rheumatol; 2000; 18(2):233-40. PubMed ID: 10812497
[TBL] [Abstract][Full Text] [Related]
19. Upregulated Chemokine and Rho-GTPase Genes Define Immune Cell Emigration into Salivary Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
Peck AB; Nguyen CQ; Ambrus JL
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281229
[TBL] [Abstract][Full Text] [Related]
20. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ; Kim H; Cornelius JG; Peck AB
J Immunol; 2007 Aug; 179(4):2318-29. PubMed ID: 17675493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
